Cargando…
Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer
BACKGROUND: The clinical outcomes of breast cancer (BC) are unpredictable due to the high level of heterogeneity and complex immune status of the tumor microenvironment (TME). When set up, multiple long non-coding RNA (lncRNA) signatures tended to be employed to appraise the prognosis of BC. Neverth...
Autores principales: | Li, Huamei, Liu, Hongjia, Hao, Qiongyu, Liu, Xianglin, Yao, Yongzhong, Cao, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386474/ https://www.ncbi.nlm.nih.gov/pubmed/35990668 http://dx.doi.org/10.3389/fimmu.2022.891175 |
Ejemplares similares
-
The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy
por: Wu, Xiaoben, et al.
Publicado: (2022) -
Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis
por: Jiang, Yong, et al.
Publicado: (2023) -
The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment
por: Guo, Yingli, et al.
Publicado: (2022) -
Long Non-Coding RNAs: Emerging and Versatile Regulators in Host–Virus Interactions
por: Meng, Xing-Yu, et al.
Publicado: (2017) -
Editorial: Long Non-coding RNAs and Immunity
por: Kwon, Grace J., et al.
Publicado: (2019)